Skip to main content
Premium Trial:

Request an Annual Quote

TIGR, Virginia Tech Sign Broad Collaboration Agreement

NEW YORK, Nov. 8 (GenomeWeb News) - The Institute for Genomic Research and Virginia Tech have signed a broad collaboration agreement, the institutions said today.


TIGR wants to build both on existing collaborations with the Virginia Bioinformatics Institute at Virginia Tech, as well as work with other groups at Virginia Tech that are involved in translational biology and high-end computing. TIGR and VBI each operate a recently funded national BioinformaticsResourceCenterto study pathogens and also plan to expand collaborations between these.


"There are clearly many areas of mutual interest and complementary capabilities at Virginia Tech and TIGR," TIGR President Claire Fraser said in a statement today. The partners plan to conduct joint research, share related facilities, appoint adjunct faculty, and involve students in research. The focus of research projects will be in microbial, plant, and animal genomics as well as functional genomics.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.